MTARC1 and Hepatic fibrosis: A recent perspective piece highlighted the importance of fit-for-purpose model selection and temporal profiling of interventions in well-established MASH and liver fibrosis models36 and the differences between the 2 independent studies characterizing the effect of Mtarc1 KO emphasize the importance of this.